Eam Investors, LLC Viking Therapeutics, Inc. Transaction History

Eam Investors, LLC

$569 Million
Q1 2024

A detailed history of Eam Investors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 73,063 shares of VKTX stock, worth $3.87 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

73,063

Previous 169,037 56.78%

Holding current value

$3.87 Million

Previous $3.15 Million 90.49%

% of portfolio

1.05%

Previous 0.62%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$17.4 - $94.5 $1.67 Million - $9.07 Million	-95,974 Reduced 56.78%	73,063 $5.99 Million
Q4 2023 Feb 13, 2024	BUY	$9.24 - $19.64 $1.56 Million - $3.32 Million	169,037 New	169,037 $3.15 Million
Q1 2023 Jul 12, 2023	BUY	$8.08 - $17.33 $2.61 Million - $5.59 Million	322,467 Added 1875.68%	339,659 $5.66 Million
Q1 2023 May 12, 2023	SELL	$8.08 - $17.33 $3.86 Million - $8.28 Million	-477,748 Reduced 96.53%	17,192 $286,000
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $1.35 Million - $4.65 Million	494,940 New	494,940 $4.65 Million

Q1 2019 May 13, 2019	SELL	$7.58 - $9.94 $1.52 Million - $1.99 Million	-200,047 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$7.16 - $16.21 $563,241 - $1.28 Million	-78,665 Reduced 28.22%	200,047 $1.53 Million
Q3 2018 Nov 08, 2018	SELL	$9.7 - $19.65 $876,588 - $1.78 Million	-90,370 Reduced 24.49%	278,712 $4.86 Million
Q2 2018 Aug 03, 2018	BUY	$3.88 - $12.74 $209,834 - $688,991	54,081 Added 17.17%	369,082 $3.5 Million
Q1 2018 May 14, 2018	SELL	$4.11 - $6.93 $261,063 - $440,186	-63,519 Reduced 16.78%	315,001 $1.38 Million
Q4 2017 May 21, 2018	SELL	$1.74 - $4.34 $428,944 - $1.07 Million	-246,520 Reduced 39.44%	378,520 $1.54 Million
Q4 2017 Feb 12, 2018	BUY	$1.74 - $4.34 $1.09 Million - $2.71 Million	625,040	625,040 $2.54 Million

Others Institutions Holding VKTX

# of Institutions

426

Shares Held

63.1M

Call Options Held

7.39M

Put Options Held

5.13M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.07B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Account

Eam Investors, LLC Viking Therapeutics, Inc. Transaction History